Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Biological markers for the clinical diagnosis of Alzheimer s disease Arai HTohoku J Exp Med 1996[Jun]; 179 (2): 65-79There is a compelling need to develop biological marker(s) to confirm a clinical diagnosis of Alzheimer's disease (AD) during life in order to unequivocally identify AD patients for emerging therapeutic interventions. This review describes recent advances in the development of diagnostic marker(s) for AD. They include polymorphism of apolipoprotein E (ApoE) and alpha 1-antichymotrypsin as well as cerebrospinal fluid (CSF) tau and CSF-amyloid beta-protein levels, skin biopsy, and pupil dilatation assay by anti-cholinergic agent. In conclusion, ApoE genotyping should not be used as a sole diagnostic test for AD, and that monitoring of CSF-tau appeared to be most promising and reliable diagnostic aid.|Aged[MESH]|Alleles[MESH]|Alzheimer Disease/*diagnosis/genetics/physiopathology[MESH]|Amyloid beta-Peptides/cerebrospinal fluid/metabolism[MESH]|Apolipoproteins E/genetics[MESH]|Biomarkers[MESH]|Humans[MESH]|Middle Aged[MESH]|Mydriatics[MESH]|Pupil/drug effects/physiology[MESH]|Skin/metabolism[MESH]|Tropicamide[MESH]|alpha 1-Antichymotrypsin/genetics[MESH]|tau Proteins/cerebrospinal fluid[MESH] |